Evolus Inc (LTS:0K16)
$ 16.611 -0.1026 (-0.62%) Market Cap: 1.04 Bil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 53.62 GF Score: 48/100

Evolus Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 05:35PM GMT
Release Date Price: $9.49
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good afternoon, everyone. So continuing this, especially from a track of the conference, we have with us our next company management team from Evolus. And so from Evolus, we have Lauren Silvernail, the CFO and VP of Corporate Development; and Rui Avelar, Chief Medical Officer and Head of R&D.

Questions & Answers

Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

So Evolus just recently had a sprint, had a pretty good number. I will get into that more in detail. But over the past couple of years, I think one of the things that I'm sure your investors that constantly asked you about was about pipeline, what is next after Jeuveau? And we're looking forward to it. And so you seem to have been tackling that now with extra strength Jeuveau. And so can you -- since we have new year, I would like to put this to you. Can you take us through the rationale of Jeuveau? And how we arrived to this point where you have an incremental pipeline or your existing commercialized product?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot